Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PLAB | RUN |
|---|---|---|
| Price | $31.07 | $7.61 |
| Change today | ▼ 1.33% | ▼ 1.30% |
| Market cap | $1.83B | $1.83B |
| Return, 3 months | +12.8% | -37.6% |
| Return, year to date | -2.9% | -58.6% |
| Return, 1 year | +24.0% | -60.5% |
| P/E (TTM) | 11.1 | 5.2 |
| P/B | 1.4 | 0.5 |
| P/E percentile vs own 5y | 39th | 69th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +41.6% | +110.4% |
| Analyst buy share | 100% | 67% |
| RSI (14) | 57 | 36 |
| 30-day volatility | 44.2% | 50.8% |
| Max drawdown, 1 year | -50.6% | -64.5% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
